Vetoquinol Global in the news
Veterinary pharmaceutical products distribution
Tamtam found 13 recent articles about Vetoquinol Global.
- A Look At Vetoquinol (ENXTPA:VETO) Valuation After Recent Share Price Weakness
Vetoquinol is currently trading at a lower P/E multiple than its industry peers following recent share price weakness and mixed long-term returns.
- Animal Healthcare Market Size Worth USD 159.56 Billion by 2034
Global animal healthcare spending is set to more than double by 2034, driven by pharmaceutical demand and rising livestock disease prevention programs.
- Tackling tapeworm topics and treatments – with Cat Henstridge and Hannah Jackson
Vetoquinol's Droncit brand is highlighting how veterinary tapeworm treatments for pets protect livestock and support the farming industry.
- Veterinary Antibiotics Market Size to Hit USD 7.19 Billion by 2034
The global veterinary antibiotics market is expected to reach $7.19 billion by 2034, driven by rising meat consumption, pet health awareness, and new digital diagnostic tools.
- Feline parasites – global insights
The document details a Vetoquinol scientific roundtable focused on addressing the growing public health risks and diagnostic challenges of feline parasites through cat-centric veterinary protocols.
- VETOQUINOL CANADA ANNOUNCES THE LAUNCH OF FLEXADIN® ESSENTIAL, AN EVOLUTION OF THE FLEXADIN LINE
Vetoquinol Canada is launching the Flexadin Essential line and phasing out older mobility supplements to simplify pet joint care options for veterinarians.
- Vetoquinol finalizes acquisition of Brazil's Clarion Biociencias
Vetoquinol expanded its presence in the Brazilian animal health market by acquiring livestock medicine specialist Clarion Biociências.
- Vetoquinol Canada launches PHOVIA®, an innovative breakthrough in veterinary dermatology
Vetoquinol Canada introduces PHOVIA®, a new Fluorescent Light Energy system to treat dermatological conditions in pets.
- Vetoquinol SA, France’s top veterinary pharmaceutical company, grows its business through a newly opened 100% owned subsidiary in Tokyo | 2022 - Events & News - Investing in Japan - Japan External Trade Organization
Vetoquinol expanded its Japanese operations by turning its joint venture into a fully owned subsidiary based in Tokyo.
- Vetoquinol: Double-digit Growth In 2021
Vetoquinol achieved 21.9% sales growth in 2021, driven by a strong performance in its 'Essential' product lines and the integration of acquired companion animal brands.
- Vetoquinol Warns of Counterfeit Zylkene Capsules
Vetoquinol USA warns customers about counterfeit Zylkene capsules sold by an unauthorized Amazon seller, offering replacements and advising caution.
- Orion Animal Health and Vetoquinol expand collaboration –
Orion Animal Health and Vetoquinol are expanding their distribution collaboration, with Vetoquinol handling Orion’s Clevor® in the USA and Orion distributing Vetoquinol’s Drontal® and Profender® products in Finland, Hungary, and Romania.
- Vetoquinol USA launches osteoarthritis drug Flexprofen
Flexprofen is a new beef-flavored chewable carprofen tablet for dog osteoarthritis and postoperative pain management.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Vetoquinol Global?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies